Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Evaluation of the effects of β-caryophyllene in patients with myocardial infarction
IRCT20220516054874N22Phase 3Recruiting
- Sponsor
- Mashhad University of Medical Sciences
- Start
- Mar 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of beta-caryophyllene in myocardial infarction (MI), sponsored by Mashhad University of Medical Sciences. Started Mar 2026; status: recruiting.
02
Drugs
beta-caryophyllene
03
Conditions
myocardial infarction (MI)
Beyond the preview
Go deeper on IRCT20220516054874N22.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20220516054874N22.